LGMD Insurance,Denials 2026
2025 LGMD Novel Therapy for Chaperone Protein Dysfunction: Dysferlin
2025 LGMD Multidisciplinary panel on general issues of clinical care and research approaches.
2025 LGMD Advocacy Panel with FDA
2025 LGMD Therapy Overview
LGMD Genetic Testing 2025
2025 Delivering ASO Therapy with Muscle Specific Vectors in AD MD1
2025 Anti Sense Oligonucleotide Therapy For Autosomal Dominant Muscle Disease (MD1)
FSHD Exercise and New Therapies
Riboflavin Deficiency SLC52A3 Variant
Case Reports RYR1, DMD, Congenital Myasthenia
Genetic Testing and Myalgia Workup
Progressive Teenage Fatigue
Early Fatigue in children